USP7 is a SUMO deubiquitinase essential for DNA replication

Nature Structural and Molecular Biology

Volumn 23, Issue 4, 2016, Pages 270-277

  Lecona, Emilio ^a   Rodriguez Acebes, Sara ^a   Specks, Julia ^a   Lopez Contreras, Andres J ^b   Ruppen, Isabel ^a   Murga, Matilde ^a   Muñoz, Javier ^a   Mendez, Juan ^a   Fernandez Capetillo, Oscar ^a,c  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; DNA; P22077; PROTEIN P53; PROTEINASE INHIBITOR; SUMO PROTEIN; UBIQUITIN SPECIFIC PROTEASE 7; UNCLASSIFIED DRUG; SUMO2 PROTEIN, HUMAN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE DELETION; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REPLISOME; UBIQUITINATION; UPREGULATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; HCT 116 CELL LINE; HELA CELL LINE; METABOLISM; MOLECULAR MODEL; SUMOYLATION;

DNA DAMAGE; DNA REPAIR; DNA REPLICATION; HCT116 CELLS; HELA CELLS; HUMANS; MODELS, MOLECULAR; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN THIOLESTERASE; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION;

EID: 84960153228     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.3185     Document Type: Article

References (71)

1. Lehmann, A.R. Ubiquitin-family modifications in the replication of DNA damage. FEBS Lett. 585, 2772-2779 (2011).
2. Zhang, W., Qin, Z., Zhang, X. &Xiao, W. Roles of sequential ubiquitination of PCNA in DNA-damage tolerance. FEBS Lett. 585, 2786-2794 (2011).
3. Havens, C.G. &Walter, J.C. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev. 25, 1568-1582 (2011).
4. Huang, T.T. et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8, 339-347 (2006).
5. Cohn, M.A. et al. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28, 786-797 (2007).
6. Nijman, S.M. et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331-339 (2005).
7. Sriramachandran, A.M. &Dohmen, R.J. SUMO-targeted ubiquitin ligases. Biochim. Biophys. Acta 1843, 75-85 (2014).
8. Galanty, Y., Belotserkovskaya, R., Coates, J. &Jackson, S.P. RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 26, 1179-1195 (2012).
9. Ragland, R.L. et al. RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells. Genes Dev. 27, 2259-2273 (2013).
10. Yin, Y. et al. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 26, 1196-1208 (2012).
11. Ulrich, H.D. Two-way communications between ubiquitin-like modifiers and DNA. Nat. Struct. Mol. Biol. 21, 317-324 (2014).
12. Davis, E.J. et al. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat. Struct. Mol. Biol. 19, 1093-1100 (2012).
13. Mosbech, A. et al. DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 19, 1084-1092 (2012).
14. Gibbs-Seymour, I. et al. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage. Mol. Cell 57, 150-164 (2015).
15. Hendriks, I.A., Schimmel, J., Eifler, K., Olsen, J.V. &Vertegaal, A.C. Ubiquitin-specific protease 11 (USP11) deubiquitinates hybrid small ubiquitin-like modifier (SUMO)-ubiquitin chains to counteract RING finger protein 4 (RNF4). J. Biol. Chem. 290, 15526-15537 (2015).
16. Psakhye, I. &Jentsch, S. Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell 151, 807-820 (2012).
17. Bursomanno, S. et al. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. DNA Repair (Amst.) 25, 84-96 (2015).
18. Bursomanno, S., McGouran, J.F., Kessler, B.M., Hickson, I.D. &Liu, Y. Regulation of SUMO2 target proteins by the proteasome in human cells exposed to replication stress. J. Proteome Res. 14, 1687-1699 (2015).
19. Schimmel, J. et al. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol. Cell 53, 1053-1066 (2014).
20. Tammsalu, T. et al. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 7, rs2 (2014).
21. Xiao, Z. et al. System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability. Mol. Cell. Proteomics 14, 1419-1434 (2015).
22. Sirbu, B.M. et al. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev. 25, 1320-1327 (2011).
23. Lopez-Contreras, A.J. et al. A proteomic characterization of factors enriched at nascent DNA molecules. Cell Rep. 3, 1105-1116 (2013).
24. Dungrawala, H. et al. The replication checkpoint prevents two types of fork collapse without regulating replisome stability. Mol. Cell 59, 998-1010 (2015).
25. Li, M., Brooks, C.L., Kon, N. &Gu, W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886 (2004).
26. Li, M. et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653 (2002).
27. Altun, M. et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem. Biol. 18, 1401-1412 (2011).
28. Chauhan, D. et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22, 345-358 (2012).
29. Reverdy, C. et al. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem. Biol. 19, 467-477 (2012).
30. Kon, N. et al. Inactivation of HAUSP in vivo modulates p53 function. Oncogene 29, 1270-1279 (2010).
31. Alonso-de Vega, I., Martín, Y. &Smits, V.A. USP7 controls Chk1 protein stability by direct deubiquitination. Cell Cycle 13, 3921-3926 (2014).
32. Colleran, A. et al. Deubiquitination of NF-κB by ubiquitin-specific protease-7 promotes transcription. Proc. Natl. Acad. Sci. USA 110, 618-623 (2013).
33. de Bie, P., Zaaroor-Regev, D. &Ciechanover, A. Regulation of the Polycomb protein RING1B ubiquitination by USP7. Biochem. Biophys. Res. Commun. 400, 389-395 (2010).
34. Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J. &Mailand, N. USP7 counteracts SCF®TpXII-but not APCXδn1-mediated proteolysis of Claspin. J. Cell Biol. 184, 13-19 (2009).
35. Khoronenkova, S.V. &Dianov, G.L. USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair. Nucleic Acids Res. 41, 1750-1756 (2013).
36. Lecona, E., Narendra, V. &Reinberg, D. USP7 cooperates with SCML2 to regulate the activity of PRC1. Mol. Cell. Biol. 35, 1157-1168 (2015).
37. Maertens, G.N., El Messaoudi-Aubert, S., Elderkin, S., Hiom, K. &Peters, G. Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J. 29, 2553-2565 (2010).
38. Qian, J. et al. USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability. Oncogene 34, 4791-4796 (2015).
39. Schwertman, P. et al. UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair. Nat. Genet. 44, 598-602 (2012).
40. Song, M.S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813-817 (2008).
41. van der Horst, A. et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 8, 1064-1073 (2006).
42. Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864-875 (2014).
43. Jagannathan, M. et al. A role for USP7 in DNA replication. Mol. Cell. Biol. 34, 132-145 (2014).
44. Du, Z. et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal. 3, ra80 (2010).
45. Felle, M. et al. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res. 39, 8355-8365 (2011).
46. Qin, W., Leonhardt, H. &Spada, F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J. Cell. Biochem. 112, 439-444 (2011).
47. Sowa, M.E., Bennett, E.J., Gygi, S.P. &Harper, J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403 (2009).
48. Ge, X.Q., Jackson, D.A. &Blow, J.J. Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev. 21, 3331-3341 (2007).
49. Ibarra, A., Schwob, E. &Méndez, J. Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc. Natl. Acad. Sci. USA 105, 8956-8961 (2008).
50. Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340 (2011).
51. Liang, Q. et al. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat. Chem. Biol. 10, 298-304 (2014).
52. Alabert, C. et al. Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components. Nat. Cell Biol. 16, 281-293 (2014).
53. Tatham, M.H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546 (2008).
54. Dantuma, N.P. &Hoppe, T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 22, 483-491 (2012).
55. Magnaghi, P. et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol. 9, 548-556 (2013).
56. Uwada, J. et al. The p150 subunit of CAF-1 causes association of SUMO2/3 with the DNA replication foci. Biochem. Biophys. Res. Commun. 391, 407-413 (2010).
57. Weinstock, J. et al. Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47. ACS Med. Chem. Lett. 3, 789-792 (2012).
58. Toledo, L.I. et al. A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat. Struct. Mol. Biol. 18, 721-727 (2011).
59. Lecona, E. et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol. Cell. Biol. 28, 4665-4674 (2008).
60. Méndez, J. &Stillman, B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20, 8602-8612 (2000).
61. Ekholm-Reed, S. et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165, 789-800 (2004).
62. Lecona, E. et al. Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes. PLoS Biol. 11, e1001737 (2013).
63. López-Contreras, A.J., Gutierrez-Martinez, P., Specks, J., Rodrigo-Perez, S. &Fernandez-Capetillo, O. An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. J. Exp. Med. 209, 455-461 (2012).
64. Gao, Z. et al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell 45, 344-356 (2012).
65. Mourón, S. et al. Repriming of DNA synthesis at stalled replication forks by human PrimPol. Nat. Struct. Mol. Biol. 20, 1383-1389 (2013).
66. Jackson, D.A. &Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J. Cell Biol. 140, 1285-1295 (1998).
67. Petermann, E., Orta, M.L., Issaeva, N., Schultz, N. &Helleday, T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37, 492-502 (2010).
68. Wisniewski, J.R., Zougman, A., Nagaraj, N. &Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
69. Wisniewski, J.R., Zougman, A. &Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 8, 5674-5678 (2009).
70. Rappsilber, J., Ishihama, Y. &Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670 (2003).
71. Udeshi, N.D., Mertins, P., Svinkina, T. &Carr, S.A. Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 8, 1950-1960 (2013).